Received Dec 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | 1 | 391315 | IM / LA |
Patient developed minor injection site pain within 48 hours of administration. The injection site pain never improved and became more severe and more widespread to include left arm bicep. At this time of presentation to office pain had persisted for about 6 weeks after vaccine was given.
orthostatic dizziness
none
none
Penicillin, sulfa
none